Comparison of the abilities of different attenuated Salmonella typhimurium strains to elicit humoral immune responses against a heterologous antigen

Infection and Immunity

Volumn 66, Issue 2, 1998, Pages 732-740

  Dunstan, Sarah J ^a   Simmons, Cameron P ^a   Strugnell, Richard A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

SALMONELLOSIS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN SPECIFICITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL MUTATION; BACTERIAL VIRULENCE; DRUG EFFICACY; FEMALE; GENE MUTATION; IMMUNOGENICITY; IMMUNOSTIMULATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PEYER PATCH; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; STRAIN DIFFERENCE; T LYMPHOCYTE ACTIVATION; VACCINE PRODUCTION;

EID: 0031882527     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.2.732-740.1998     Document Type: Article

References (38)

1. Binotto, J., P. MacLachan, and K. E. Sanderson. 1991. Elcctrotransformation in Salmonella typhimurium LT2 strains. Can. J. Microbiol. 37:474-177.
2. + for all three chromosomally located systems of DNA restriction and modification. J. Bacteriol. 156:471-474.
3. Chabalgoity, J. A., C. M. A. Khan, A. A. Nash, and C. E. Hormaeche. 1996. A Salmonella typhimurium htrA live vaccine expressing multiple copies of a peptide comprising amino acids 8-23 of herpes simplex virus glycoprotein D as a genetic fusion to tetanus toxin fragment C protects mice from herpes simplex infection. Mol. Microbiol. 19:791-801.
4. Chatfield, S. N., K. Strahan, D. Pickard, I. G. Charles, C. E. Hormaeche, and G. Dougan. 1992. Evaluation of Salmonella typhimurium strains harbouring defined mutations in htrA and aroA in the murine salmonellosis model. Microb. Pathog. 12:145-151.
5. Collins, F. M. 1974. Vaccines and cell-mediated immunity. Bacteriol. Rev. 38:371-402.
6. Curtiss, R., III, and S. M. Kelly. 1987. Salmonella typhimurium deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenic. Infect. Immun. 55:3035-3043.
7. Curtiss, R., III, R. M. Goldschmidt, N. B. Fletchall, and S. M. Kelly. 1988. Avirulent Salmonella typhimurium cya crp oral vaccine strains expressing a streptococcal colonisation and virulence antigen. Vaccine 6:155-160.
8. Dorman, C. J., S. Chatfield, C. F. Higgins, C. Hayward, and G. Dougan. 1989. Characterization of porin and ompR mutants of a virulent strain of Salmonella typhimurium: ompR mutants are attenuated in vivo. Infect. Immun. 57:2136-2140.
9. Eisenstein, T. K., and B. M. Sultzer. 1983. Immunity to Salmonella infections. Adv. Exp. Med. Biol. 162:261-296.
10. Fairweather, N. F., S. Chatfield, A. J. Makoff, R. A. Strugnell, J. Bester, D. J. Masked, and G. Dougan. 1990. Oral vaccination of mice against tetanus by use of a live attenuated Salmonella carrier. Infect. Immun. 58:1323-1326.
11. Finlay, B. B. 1994. Molecular and cellular mechanisms of Salmonella pathogenesis. Curr. Top. Microbiol. Immunol. 192:163-185.
12. Galán, J. E., and R. Curtiss III. 1989. Virulence and vaccine potential of phoP mutants of Salmonella typhimurium. Microb. Pathog. 6:433-443.
13. Guo, L., K. B. Lim, J. S. Gunn, B. Bainbridge, R. P. Darveau, M. Hackett, and S. I. Miller. 1997. Regulation of lipid A modifications by Salmonella typhimurium virulence genes phoP-phoQ. Science 276:250-253.
14. Halting, T. B., and H. H. Nau. 1984. Analysis of the immune response to papain digestion products of tetanus toxin. Acta Pathol. Microbiol. Immunol. Scand. Sect. C 92:59-63.
15. Hoiseth, S. K., and B. A. D. Stocker. 1981. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 291:238-239.
16. Jagusztyn-Krynicka, E., J. E. Clarke-Curtiss, and R. I. Curtiss. 1993. Escherichia coli heat-labile toxin subunit B fusions with Streptococcus sobrinus antigens expressed by Salmonella typhimurium oral vaccine strains: importance of the linker for antigenicity and biological activities of the hybrid proteins. Infect. Immun. 61:1004-1015.
17. Jones, B. D., and S. Falkow. 1996. Salmonellosis: Host immune responses and bacterial virulence determinants. Annu. Rev. Immunol. 14:533-561.
18. Julius, M. H., E. Simpson, and L. A. Herzenberg. 1973. A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur. J. Immunol. 3:645-649.
19. Karem, K. L., S. Chatfield, N. Kuklin, and B. T. Rousse. 1995. Differential induction of carrier antigen-specific immunity by Salmonella typhimurium live-vaccine strains after single mucosal or intravenous immunization of BALB/c mice. Infect. Immun. 63:4557-4563.
20. Rung, V. T., and G. M. K. Humphries. 1987. Kinetic ELISA in microtitre plates. Clin. Chem. 33:1573-1574.
21. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
22. Makoff, A. J., M. D. Oxer, M. A. Romanes, N. F. Fairweather, and S. Ballantine. 1989. Expression of tetanus toxin fragment C in E. coli: high level expression by removing rare codons. Nucleic Acids Res. 17:10191-10202.
23. McFarland, W. C., and B. A. D. Stocker. 1987. Effect of different purine auxotrophic mutations on mouse-virulence of a Vi-positive strain of Salmonella dublin and of two strains of Salmonella typhimurium. Microb. Pathog. 3:129-141.
24. Miller, S. I., A. M. Kukral, and J. J. Mekalanos. 1989. A two-component regulatory system (phoP phoQ) controls Salmonella typhimurium virulence. Proc. Natl. Acad. Sci. USA 86:5054-5058.
25. Mosmann, T. R., and R. L. Coffman. 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145-173.
26. O'Callaghan, D., D. Maskell, F. Y. Liew, C. S. Easmon, and G. Dougan. 1988. Characterization of aromatic- and purine-dependent Salmonella typhimurium: attenuation, persistence, and ability to induce protective immunity in BALB/c mice. Infect. Immun. 56:419-423.
27. Plant, J., and A. A. Glynn. 1976. Genetics of resistance to infection with Salmonella typhimurium in mice. J. Infect. Dis. 133:72-78.
28. Redman, T. K., C. C. Harmon, R. L. Lallone, and S. M. Michalek. 1995. Oral immunization with recombinant Salmonella typhimurium expressing surface protein antigen A of Streptococcus sobrinus: dose response and induction of protective humoral response in rats. Infect. Immun. 63:2004-2011.
29. Reeves, P. R. 1994. Biosynthesis and assembly of lipopolysaccharide. New Compr. Biochem. 27:281-314.
30. Roberts, M., S. N. Chatfield, and G. Dougan. 1994. Salmonella as carriers of heterologous antigens, p. 27-58. In D. T. O'Hagan (ed.). Novel delivery systems for oral vaccines. CRC Press, Inc., Boca Raton. Fla.
31. Stabel, T. J., J. E. Mayfield, L. B. Tabatabai, and M. J. Wannemuehler. 1990. Oral immunization of mice with attenuated Salmonella typhimurium containing a recombinant plasmid which codes for production of a 31-kilodalton protein of Brucella abortis. Infect. Immun. 58:2048-2055.
32. Stevens, T. L., A. Bossie, W. M. Sanders, R. Fernandez-Botran. R. L. Coffman, T. R. Mosmann, and E. S. Vitetta. 1988. Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells. Nature 334:255-258.
33. Tacket, C. O., M. B. Sztein, G. A. Losonsky, S. S. Wasserman, J. P. Nataro, R. Edelman, D. Pickard, G. Dougan, S. N. Chatfield, and M. M. Levine. 1997. Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune responses in humans. Infect. Immun. 65:452-456.
34. Tacket, C. O., D. M. Hone, G. A. Losonsky, L. Guers, R. Edelman, and M. M. Levine. 1992. Clinical acceptability and immunogenicity of CVD908 Salmonella typhi vaccine strain. Vaccine 10:443-446.
35. Towbin, H. T., T. Staehelin, and J. Gordon. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76:4350-4354.
36. Tsang, V. C., R. C. Wilson, and J. M. Peralta. 1983. Quantitative single tube kinetic dependent K-ELISA assay. Methods Enzymol. 92:391-403.
37. Turner, S. J., F. R. Carbone, and R. A. Strugnell. 1993. Salmonella typhimurium ΔaroA ΔaroD mutants expressing a foreign recombinam protein induce specific major histocompatibility complex class I-restricted cytotoxic T lymphocytes in mice. Infect. Immun. 61:5374-5380.
38. VanCott, J. L., H. F. Staats, D. W. Pascual, M. Roberts, S. N. Chatfield, M. Yamamoto, M. Coste, P. B. Carter, H. Kiyono, and J. R. McGhee. 1996. Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages and derived cytokines following oral immunisations with live recombinant Salmonella. J. Immunol. 156:1504-1514.